Tan Wei Phin, Whelan Patrick, Deane Leslie A
Department of Urology, Rush University Medical Center, Chicago, IL.
Department of Urology, Rush University Medical Center, Chicago, IL.
Urology. 2017 Apr;102:116-120. doi: 10.1016/j.urology.2017.01.014. Epub 2017 Jan 19.
To describe the surgical technique we used to perform a stentless intracorporeal ureteroenteric anastomosis and to determine the outcomes in this initial series.
We performed a retrospective review of a prospective database of all patients undergoing robotic-assisted intracorporeal urinary diversion with stentless ureteroenteric anastomosis between March 2014 and July 2016. Diversions were performed at the time of either robotic-assisted laparoscopic cystectomy for bladder cancer or urinary diversion for other indications.
A total of 10 patients underwent implantation of 20 ureters into the intestine via a robotic-assisted approach with intentional omission of stents. Median body mass index was 29.57 (first quartile 23.68, third quartile 34.69). Median American Society of Anesthesiologists score was 3 (range 2-3). Seven patients had intracorporeal ileal conduit reconstruction and 3 patients had an intracorporeal neobladder creation. There were no patients who developed a stricture of the ureter nor did any patient develop a leak at the ureteroenteric anastomosis. All patients had normal serum creatinine at least 4 weeks after surgery, and all patients had follow-up computed tomography of the kidneys, which were normal. The median follow-up was 8 months (first quartile = 3 months, third quartile = 17 months).
Robotic intracorporeal urinary diversion with intentional omission of ureteral stents is a safe and feasible option when establishing continuity of the genitourinary and gastrointestinal tracts.
描述我们用于进行无支架体内输尿管肠吻合术的手术技术,并确定这一初始系列病例的治疗结果。
我们对一个前瞻性数据库进行了回顾性分析,该数据库收录了2014年3月至2016年7月期间所有接受机器人辅助体内尿流改道术并采用无支架输尿管肠吻合术的患者。尿流改道术在机器人辅助腹腔镜膀胱癌膀胱切除术或因其他适应证进行尿流改道时实施。
共有10例患者通过机器人辅助方法将总计20条输尿管植入肠道,术中特意未放置支架。体重指数中位数为29.57(第一四分位数为23.68,第三四分位数为34.69)。美国麻醉医师协会评分中位数为3(范围为2 - 3)。7例患者进行了体内回肠导管重建术,3例患者进行了体内新膀胱创建术。没有患者发生输尿管狭窄,也没有患者在输尿管肠吻合处出现漏尿。所有患者术后至少4周血清肌酐水平正常,且所有患者均接受了肾脏的随访计算机断层扫描,结果均正常。中位随访时间为8个月(第一四分位数 = 3个月,第三四分位数 = 17个月)。
在建立泌尿生殖道与胃肠道连续性时,有意省略输尿管支架的机器人辅助体内尿流改道术是一种安全可行的选择。